Silver Polydiguanide Complex for Stable Burn Wound Care

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibacterial agents containing monovalent silver are not pharmaceutically acceptable for burn and wound care due to instability and photosensitivity, while divalent silver agents face challenges with long-term storage stability and water solubility, limiting their application.

Innovation Solution

Development of a microcrystalline or nanocrystalline silver/polydiguanide complex with a mole ratio of 1:1-4 and zeta potential greater than or equal to zero, which is stable in various oxidation states and exhibits enhanced antibacterial activity with a lower minimal inhibitory concentration compared to silver sulfadiazine.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If monovalent silver antibacterial agents are used, then good antibacterial efficacy is achieved, but photosensitivity and instability occur causing discoloration upon exposure to electromagnetic radiation

Engineering Contradiction:
Improveantibacterial efficacyVSAvoidphotosensitivity and stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent changes the oxidation state parameter of silver from monovalent (Ag+) to divalent (Ag2+), which fundamentally alters the chemical properties. This parameter change eliminates photosensitivity and improves stability while maintaining or enhancing antibacterial efficacy, as divalent silver does not undergo the same photodisproportionation reactions that cause discoloration in monovalent silver compounds.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite antibacterial agent by combining divalent silver with organic ligands or polymers to form stable complexes. This composite approach allows the divalent silver to maintain its superior stability and antibacterial properties while the organic components provide additional functionality and enhance overall compound stability for pharmaceutical applications.

Inventive Principle:
Principle #40Composite materials

2Reliability

If divalent silver antibacterial agents are used, then stronger and more effective antibacterial action is achieved, but long-term storage stability and water solubility are limited

Engineering Contradiction:
Improveantibacterial performanceVSAvoidlong-term storage stability and solubility
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces organic ligands, chelating agents, or polymer matrices as intermediaries to stabilize divalent silver. These intermediary substances coordinate with the divalent silver ions, preventing their reduction to metallic silver or precipitation as insoluble oxides, thereby maintaining both solubility and stability during storage while preserving the potent antibacterial activity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the chemical environment parameters by adjusting pH, ionic strength, and coordinating group concentrations to optimize the stability and solubility of divalent silver compounds. By controlling these parameters, the patent achieves a balance where divalent silver remains soluble and stable in aqueous pharmaceutical formulations without compromising its enhanced antibacterial performance.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS9108987B2Silver/polydiguanide complex, preparation method thereof, and antibacterial composition containing the same as an active ingredient
Publication Date: 2015.08.18 SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
  • US9108987B2 patent drawing
  • US9108987B2 patent drawing
  • US9108987B2 patent drawing

AI summary

The present invention relates to a silver/polydiguanide complex and derivatives thereof including silver and polydiguanide having at least two biguanide moieties, wherein the silver is stabilized in an oxidation state of an integer of 0 to 4, a mole ratio between the silver and the polydiguanide is 1:1-4, an average particle diameter of the complex is micrometer or nanometer, and zeta potential of the complex is greater than or equal to zero, a preparation method thereof, and an antibacterial composition for burns or wounds treatment including the same as an active ingredient. A silver/polydiguanide complex according to the present invention is different from conventional silver/polydiguanide complexes in carbon, hydrogen, and nitrogen contents as well as in structure of silver and polydiguanide, and solubility, is a material that exhibits a very good antibacterial activity due to a much lower minimal inhibitory concentration (MIC) value by 10 to 100 folds or more compared to silver sulfadiazine which is a conventional therapeutic agent for burns, and may be usefully used as an antibacterial composition for burns or wounds treatment.